(Q63340992)

English

Safety Study Evaluating the Adrenal Suppression Potential of Product 0405 in Pediatric Subjects With Atopic Dermatitis

clinical trial

Statements

0405-01-04 (English)
0 references
An Open-Label Evaluation of the Adrenal Suppression Potential of Product 0405 in the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric Subjects (English)
0 references
0 references
0 references
November 2010
0 references
August 2011
0 references
114
0 references
3 month
0 references
17 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit